EOM 1352: Fri 7 June 2024, 11:36

Current Edition

ramusmedical
Europe

Promising clinical trial results of tucatinib with T-DM1 against HER2+ breast cancer

Virginia Borges, MD, MMSc, Phase 1b clinical trial results published in JAMA Oncology show pr...
Continue Reading →
Europe

Cannabics Pharma clinches clinical trial on Cannabics SR 5mg for CACS

The company is awaiting for the results and expect them to further clarify an important part of their mission in integrating cannabinoid-based therapies into the worl...
Continue Reading →
Europe

After failure, Zynerba shifts gears to save cash

Zynerba Pharmaceuticals on Thursday announced negative topline results from a Phase 1 safety and dosing study of its transdermal tetrahydrocannabinol patch ZYN001,...
Continue Reading →
Europe

Leadless Pacemaker Patients Less Likely to Experience Complications, Major U.S. Study Shows

Research finds use of smaller, self-contained devices reduced complications for up to 18 months compared with conventional designs Pacemakers that don’t use wires to...
Continue Reading →
Europe

MEDEI Launches Global Support Program for MedTech Start-Ups

Intelligent data management software offer will enable MedTech start-ups to bring new devices to market faster in compliance with toughening EU medical regulations A...
Continue Reading →
Europe

Bavarian Nordic Announces Initiation of Phase 2 Trial Evaluating the Combination Therapy of CV301 and Nivolumab in Metastatic Colorectal Cancer

Investigator-led study has commenced dosing Immunotherapy candidate CV301 is being assessed in combination with checkpoint inhibitors in multiple solid tumors B...
Continue Reading →
Europe

OncBioMune Signs Work Order for Phase 2 Clinical Trial of ProscaVax for Early Stage Prostate Cancer

Opthea Recruits 176th Patient and On-Track to Report Primary Data Analysis Early 2020 OncBioMune Pharmaceuticals, Inc. (OTCQB:OBMP) ("OncBioMune" or the "Company"), a...
Continue Reading →
Europe

Atlantic Health System enrolling patients in pancreatic cancer clinical trials

Angela Alistar, M.D., director of GI medical oncology at the Carol G. Simon Cancer Center of Morristown Medical Center,...
Continue Reading →
Europe

Opthea’s Phase 2b Wet AMD Clinical Trial Reaches Mid-Way Point of Patient Recruitment

Opthea Recruits 176th Patient and On-Track to Report Primary Data Analysis Early 2020 Opthea Limited (ASX:OPT), a late stage biopharmaceutical company developing nove...
Continue Reading →
Europe

Compugen Advancing Cancer Immunotherapies to Clinical Trials

Compugen today said clinical trials will be launched for a pair of its cancer immunotherapy candidates targeting advanced solid tumors—its lead immuno-oncology progra...
Continue Reading →
Quotient